NuCana annual r&d spending
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
NuCana R&D Spending Growth & History (NCNA)
NuCana's r&d spending was £12.7M for fiscal 2025.
View full NuCana company overviewNuCana annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £12.7M | −£5.3M | −29.31% |
| 2024 | 2024-12-31 | £18.0M | −£7.0M | −28.11% |
| 2023 | 2023-12-31 | £25.1M | −£11.4M | −31.20% |
| 2022 | 2022-12-31 | £36.4M | −£408,000 | −1.11% |
| 2021 | 2021-12-31 | £36.8M | £10.9M | +42.22% |
| 2020 | 2020-12-31 | £25.9M | £6.2M | +31.28% |
| 2019 | 2019-12-31 | £19.7M | £2.9M | +17.11% |
| 2018 | 2018-12-31 | £16.8M | −£827,000 | −4.68% |
| 2017 | 2017-12-31 | £17.7M | £9.8M | +123.60% |
| 2016 | 2016-12-31 | £7.9M | £2.2M | +39.77% |
| 2015 | 2015-12-31 | £5.7M | — | — |
NuCana quarterly r&d spending
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q2.22
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | £2.3M | −£4.9M | −68.33% |
| Q1 2026 | 2026-03-31 | £3.2M | £1.5M | +86.26% |
| Q4 2025 | 2025-12-31 | £1.7M | — | — |
| Q3 2025 | 2025-09-30 | £2.2M | — | — |
| Q2 2025 | 2025-06-30 | £7.1M | £335,000 | +4.95% |
| Q1 2025 | 2025-03-31 | £1.7M | — | — |
| Q2 2024 | 2024-06-30 | £6.8M | £2.8M | +70.98% |
| Q2 2023 | 2023-06-30 | £4.0M | −£2.4M | −38.20% |
| Q2 2022 | 2022-06-30 | £6.4M | −£2.1M | −24.84% |
| Q4 2021 | 2021-12-31 | £10.6M | £2.7M | +33.24% |
| Q3 2021 | 2021-09-30 | £9.0M | £2.9M | +46.66% |
| Q2 2021 | 2021-06-30 | £8.5M | £2.7M | +45.37% |
| Q1 2021 | 2021-03-31 | £8.7M | £2.8M | +46.62% |
| Q4 2020 | 2020-12-31 | £8.0M | £2.8M | +54.16% |
| Q3 2020 | 2020-09-30 | £6.1M | £1.3M | +26.25% |
| Q2 2020 | 2020-06-30 | £5.9M | £507,000 | +9.47% |
| Q1 2020 | 2020-03-31 | £5.9M | £1.6M | +36.51% |
| Q4 2019 | 2019-12-31 | £5.2M | £527,000 | +11.33% |
| Q3 2019 | 2019-09-30 | £4.8M | £1.5M | +45.36% |
| Q2 2019 | 2019-06-30 | £5.4M | £198,000 | +3.84% |
| Q1 2019 | 2019-03-31 | £4.3M | £645,000 | +17.41% |
| Q4 2018 | 2018-12-31 | £4.7M | — | — |
| Q3 2018 | 2018-09-30 | £3.3M | −£6.8M | −67.25% |
| Q2 2018 | 2018-06-30 | £5.2M | £3.1M | +148.34% |
| Q1 2018 | 2018-03-31 | £3.7M | — | — |
| Q3 2017 | 2017-09-30 | £10.2M | — | — |
| Q2 2017 | 2017-06-30 | £2.1M | — | — |
NuCana r&d spending trends
Over the last five fiscal years, NuCana's r&d spending decreased from £25.9M to £12.7M, a change of −£13.2M. The latest reported quarter, Q2 2026, shows £2.3M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NuCana source filings ↗